STOCKHOLM, September 30, 2022 /PRNewswire/ — According to September 30, 2022the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) is 309,804,782 shares. All shares are common shares. The total number of votes is 309,804,782. The increase in the number of shares and votes resulted from the issuance of 2,690,287 Class C shares. The Class C shares were issued to ensure the fulfillment of employee stock option plan obligations and became common shares by virtue of the conversion clause in the Articles of Association transformed. acc September 30, 2022 The company holds 13,813,835 common shares.
Sobi®
Sobi is a specialty international biopharmaceutical company transforming the lives of people living with rare diseases. Sobi offers sustainable access to innovative medicines in the fields of hematology, immunology and special care and employs around 1,600 people Europe, North Americathe middle East and Asia. In 2021, the revenue amounted to 15.5 billion SEK. Sobi’s share SOBI is listed on Nasdaq Stockholm. More about Sobi under sobi.com, LinkedIn and youtube.
contacts
Details on how to contact the Sobi Investor Relations team can be found here here. Click for Sobi Media contacts here.
This information has been published in accordance with the Swedish Act on Trading in Financial Instruments. The information has been submitted for publication at 08:00 CEST on September 30, 2022.
This information was provided to you by Cision http://news.cision.com
The following files are available for download:
Show original content:https://www.prnewswire.com/news-releases/new-number-of-shares-and-votes-in-swedish-orphan-biovitrum-ab-publ-301637520.html
SOURCE Swedish Orphan Biovitrum AB
